IL122451A0 - Oxidant scavengers - Google Patents

Oxidant scavengers

Info

Publication number
IL122451A0
IL122451A0 IL12245196A IL12245196A IL122451A0 IL 122451 A0 IL122451 A0 IL 122451A0 IL 12245196 A IL12245196 A IL 12245196A IL 12245196 A IL12245196 A IL 12245196A IL 122451 A0 IL122451 A0 IL 122451A0
Authority
IL
Israel
Prior art keywords
oxidants
relates
oxidant scavengers
scavengers
oxidant
Prior art date
Application number
IL12245196A
Other languages
English (en)
Original Assignee
Univ Duke
Univ Alabama Res Found
Trova Michael P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/476,866 external-priority patent/US5994339A/en
Application filed by Univ Duke, Univ Alabama Res Found, Trova Michael P filed Critical Univ Duke
Publication of IL122451A0 publication Critical patent/IL122451A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545Heterocyclic compounds
    • A61K47/546Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0089Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL12245196A 1995-06-07 1996-06-07 Oxidant scavengers IL122451A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/476,866 US5994339A (en) 1993-10-15 1995-06-07 Oxidant scavengers
US61341896A 1996-03-11 1996-03-11

Publications (1)

Publication Number Publication Date
IL122451A0 true IL122451A0 (en) 1998-06-15

Family

ID=27045322

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12245196A IL122451A0 (en) 1995-06-07 1996-06-07 Oxidant scavengers

Country Status (9)

Country Link
EP (1) EP0831891B1 (de)
JP (1) JPH11509180A (de)
AT (1) ATE306936T1 (de)
AU (1) AU725602B2 (de)
CA (1) CA2223407C (de)
DE (1) DE69635304T2 (de)
ES (1) ES2249784T3 (de)
IL (1) IL122451A0 (de)
WO (1) WO1996040223A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US5834457A (en) * 1996-01-26 1998-11-10 The Regents Of The University Of California Method of modulating radical formation by mutant cuznsod enzymes
WO1999023097A1 (en) 1997-11-03 1999-05-14 Duke University Substituted porphyrins
ES2257858T3 (es) 1998-04-24 2006-08-01 Duke University Porfirinas sustituidas.
US6632808B1 (en) 1998-08-11 2003-10-14 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors of amyloid formation
EP1107971B1 (de) 1998-08-28 2004-11-24 Destiny Pharma Limited Porphyrin derivate, ihre verwendung in der photodynamischen therapie und diese enthaltende medizinische geräte
ATE312103T1 (de) * 1999-01-25 2005-12-15 Nat Jewish Med & Res Center Substituierte porphyrine und deren therapeutische verwendungen
US6403788B1 (en) 2000-07-11 2002-06-11 Eukarion, Inc. Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species
EP1439842A4 (de) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center Oxidantienfänger zur behandlung von diabetes oder zur verwendung bei der transplantation oder induktion von immuntoleranz
US7485721B2 (en) 2002-06-07 2009-02-03 Duke University Substituted porphyrins
ITFI20020200A1 (it) * 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
US7740839B2 (en) * 2003-10-31 2010-06-22 Tae-Yoon Kim EC SOD and cell transducing EC SOD and use thereof
US8318803B2 (en) 2003-10-31 2012-11-27 Tae-Yoon Kim EC SOD and use thereof
BRPI0509359A (pt) * 2004-03-29 2007-09-04 Inotek Pharmaceuticals Corp compostos de porfirina substituìda por piridila e métodos de empregos destes
EP1928467A4 (de) 2005-09-28 2009-11-04 Inotek Pharmaceuticals Corp N-benzyl-substituierte pyridylporphyrin-verbindungen und anwendungsverfahren dafür
WO2008114017A2 (en) * 2007-03-19 2008-09-25 Imperial Innovations Limited Compositions and methods relating to influenza infection
CN102088991A (zh) 2008-05-13 2011-06-08 堪萨斯大学 金属提取肽标签和相关方法
CN102105146A (zh) 2008-05-23 2011-06-22 国立犹太保健医院 用于治疗与暴露于烷化物质有关的损伤的方法
EP2759546B1 (de) * 2011-09-21 2018-03-21 National University Corporation Okayama University Metallporphyrinkomplex, herstellungsverfahren dafür, seine verwendung als kohlendioxidfixierungskatalysator und verfahren zur herstellung von zyklischen carbonaten
CN102584836B (zh) * 2011-12-31 2014-04-16 中国科学院化学研究所 一种卟啉笼状化合物及其制备方法与应用
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
JP6444211B2 (ja) * 2015-02-24 2018-12-26 学校法人同志社 ポルフィリン誘導体、及びこれを含む光増感剤等
CN105399750B (zh) * 2015-12-11 2018-07-17 西北师范大学 四氮唑卟啉金属配合物及其合成和作为染料敏化剂的应用
CN112694887B (zh) * 2020-12-07 2024-04-26 黑龙江省农业科学院植物保护研究所 一种发光型传感器及其构筑方法与在检测植物水杨酸含量中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3464252D1 (en) * 1983-06-03 1987-07-23 Hoffmann La Roche Labelled molecules for fluorescence immunoassays and processes and intermediates for their preparation
GB8429845D0 (en) * 1984-11-26 1985-01-03 Efamol Ltd Porphyrins & cancer treatment
US5248603A (en) * 1985-09-03 1993-09-28 Symbicom Aktiebolag Superoxide dismutase
US4746735A (en) * 1986-11-21 1988-05-24 The Dow Chemical Company Regiospecific aryl nitration of meso-substituted tetraarylporphyrins
US4892941A (en) * 1987-04-17 1990-01-09 Dolphin David H Porphyrins
US5051337A (en) * 1987-06-10 1991-09-24 Director-General Of Agency Of Industrial Science And Technology Optical recording material
GB8805849D0 (en) * 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
DE3809671A1 (de) * 1988-03-18 1989-09-28 Schering Ag Porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
FR2632187B1 (fr) * 1988-06-02 1990-09-14 Centre Nat Rech Scient Derives de metalloporphyrines, leur preparation, leur application en therapeutique et leur utilisation pour la preparation de molecules hybrides
US5171680A (en) * 1988-06-14 1992-12-15 Chiron Corporation Superoxide dismutase analogs having novel binding properties
DK455789D0 (da) * 1989-09-15 1989-09-15 Symbicom Ab Polypeptid
US5236915A (en) * 1990-05-31 1993-08-17 Health Research, Inc. Meso poly(4-sulfonatophenyl) porphines as MRI image enhancing agents
FR2676738B1 (fr) * 1991-05-22 1995-05-05 Ir2M Nouveau derive organique de metal de transition a structure porphyrinique, composition therapeutique le contenant, en particulier a activite hypoglycemiante.
US5262532A (en) * 1991-07-22 1993-11-16 E.R. Squibb & Sons, Inc. Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants

Also Published As

Publication number Publication date
CA2223407A1 (en) 1996-12-19
DE69635304T2 (de) 2006-07-20
EP0831891B1 (de) 2005-10-19
JPH11509180A (ja) 1999-08-17
CA2223407C (en) 2011-02-08
AU725602B2 (en) 2000-10-12
EP0831891A1 (de) 1998-04-01
AU6387096A (en) 1996-12-30
EP0831891A4 (de) 1999-02-03
ATE306936T1 (de) 2005-11-15
ES2249784T3 (es) 2006-04-01
WO1996040223A1 (en) 1996-12-19
DE69635304D1 (de) 2006-03-02

Similar Documents

Publication Publication Date Title
IL122451A0 (en) Oxidant scavengers
IL135949A0 (en) Substituted porphyrins
MXPA01007451A (es) Porfirinas sustituidas.
EP0723398A4 (de) Superoxiddismutase und ihre memetika
DK1071474T3 (da) Substituerede porphyriner
NL300787I2 (de)
AU5624699A (en) Use of 5ht-6 antagonists
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
HK1043472A1 (zh) 血小板减少症拟态
WO1999004752A3 (en) Methods for treating skin pigmentation
MX9709240A (es) Fenilpiridazinonas.
IL110943A0 (en) Compositions for the treatment of skin disorders
PL336482A1 (en) Application of zinc hyaluronate against a peptic ulcer
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
IL143516A (en) E3 ubiquitin ligase polypeptide, polynucleotide encoding the same and uses thereof
DE69606321D1 (de) Stabilisiertes sonnenschutzmittel
WO1996031208A3 (de) Verwendung von substituierten piperidin- oder pyrrolidinverbindungen zur behandlung von sigma-rezeptor modulierten krankheiten
HU9601498D0 (en) Use of dimeticone for treating constipation
MX9708091A (es) Metodo de elaboracion de un alimento para animales que tiene una suspension estable de psyllium.
ZA972594B (en) Compositions cosmetiques filtrantes contenant un dibenzoylmethane, un beta, beta'-diphenylaerylate d'alkyle et une silicone benzotriazole et utilisations.
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
UA20075A (uk) Спосіб діагhостуваhhя та лікуваhhя стійких фуhкціоhальhих зміщеhь hижhьої щелепи
GB9818650D0 (en) Therapeutic compounds and methods of making and using the same
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them
MX9804579A (es) Composiciones que contienen bismuto para la prevencion y tratamiento de trastornos gastrointestinales.